These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9357143

  • 1. CD6-ligand interactions: a paradigm for SRCR domain function?
    Aruffo A, Bowen MA, Patel DD, Haynes BF, Starling GC, Gebe JA, Bajorath J.
    Immunol Today; 1997 Oct; 18(10):498-504. PubMed ID: 9357143
    [Abstract] [Full Text] [Related]

  • 2. Mutational analysis of the CD6 ligand binding domain.
    Skonier JE, Bodian DL, Emswiler J, Bowen MA, Aruffo A, Bajorath J.
    Protein Eng; 1997 Aug; 10(8):943-7. PubMed ID: 9415444
    [Abstract] [Full Text] [Related]

  • 3. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
    Whitney GS, Starling GC, Bowen MA, Modrell B, Siadak AW, Aruffo A.
    J Biol Chem; 1995 Aug 04; 270(31):18187-90. PubMed ID: 7543097
    [Abstract] [Full Text] [Related]

  • 4. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
    Bowen MA, Aruffo AA, Bajorath J.
    Proteins; 2000 Aug 15; 40(3):420-8. PubMed ID: 10861932
    [Abstract] [Full Text] [Related]

  • 5. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
    Bowen MA, Bajorath J, Siadak AW, Modrell B, Malacko AR, Marquardt H, Nadler SG, Aruffo A.
    J Biol Chem; 1996 Jul 19; 271(29):17390-6. PubMed ID: 8663238
    [Abstract] [Full Text] [Related]

  • 6. The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system.
    Sarrias MR, Grønlund J, Padilla O, Madsen J, Holmskov U, Lozano F.
    Crit Rev Immunol; 2004 Jul 19; 24(1):1-37. PubMed ID: 14995912
    [Abstract] [Full Text] [Related]

  • 7. Identification of residues in CD6 which are critical for ligand binding.
    Bodian DL, Skonier JE, Bowen MA, Neubauer M, Siadak AW, Aruffo A, Bajorath J.
    Biochemistry; 1997 Mar 04; 36(9):2637-41. PubMed ID: 9054570
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
    Bowen MA, Bajorath J, D'Egidio M, Whitney GS, Palmer D, Kobarg J, Starling GC, Siadak AW, Aruffo A.
    Eur J Immunol; 1997 Jun 04; 27(6):1469-78. PubMed ID: 9209500
    [Abstract] [Full Text] [Related]

  • 11. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily.
    Hohenester E, Sasaki T, Timpl R.
    Nat Struct Biol; 1999 Mar 04; 6(3):228-32. PubMed ID: 10074941
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A cDNA clone from the sea lamprey Petromyzon marinus coding for a scavenger receptor Cys-rich (SRCR) domain protein.
    Mayer WE, Tichy H.
    Gene; 1995 Oct 27; 164(2):267-71. PubMed ID: 7590341
    [Abstract] [Full Text] [Related]

  • 14. Partial cDNA sequences of bovine CD72 and CD166/ALCAM, ligands for SRCR-family accessory molecules CD5 and CD6.
    Rogers AN, Welte S, Black SJ, Baldwin CL.
    Vet Immunol Immunopathol; 2002 Mar 27; 85(3-4):233-9. PubMed ID: 11943324
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The putative sponge aggregation receptor. Isolation and characterization of a molecule composed of scavenger receptor cysteine-rich domains and short consensus repeats.
    Blumbach B, Pancer Z, Diehl-Seifert B, Steffen R, Münkner J, Müller I, Müller WE.
    J Cell Sci; 1998 Sep 27; 111 ( Pt 17)():2635-44. PubMed ID: 9701562
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
    Le Dantec C, Alonso R, Fali T, Montero E, Devauchelle V, Saraux A, Pers JO, Renaudineau Y.
    Immunol Res; 2013 Jul 27; 56(2-3):341-7. PubMed ID: 23576060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.